Cargando…

Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer

Detalles Bibliográficos
Autor principal: Konecny, Gottfried E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557782/
https://www.ncbi.nlm.nih.gov/pubmed/30979685
http://dx.doi.org/10.1016/j.ebiom.2019.04.009
_version_ 1783425491999391744
author Konecny, Gottfried E.
author_facet Konecny, Gottfried E.
author_sort Konecny, Gottfried E.
collection PubMed
description
format Online
Article
Text
id pubmed-6557782
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65577822019-06-13 Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer Konecny, Gottfried E. EBioMedicine Commentary Elsevier 2019-04-09 /pmc/articles/PMC6557782/ /pubmed/30979685 http://dx.doi.org/10.1016/j.ebiom.2019.04.009 Text en Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Konecny, Gottfried E.
Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
title Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
title_full Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
title_fullStr Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
title_full_unstemmed Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
title_short Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancer
title_sort combining parp and cdk4/6 inhibitors in myc driven ovarian cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557782/
https://www.ncbi.nlm.nih.gov/pubmed/30979685
http://dx.doi.org/10.1016/j.ebiom.2019.04.009
work_keys_str_mv AT konecnygottfriede combiningparpandcdk46inhibitorsinmycdrivenovariancancer